Related Experiment Video
Updated: Jun 10, 2026

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy
Published on: October 6, 2014
Up for Mischief? IL-17/Th17 in the tumour microenvironment
E Maniati1, R Soper, T Hagemann
1Centre for Cancer and Inflammation, Institute of Cancer, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Interleukin (IL)-17 and T helper 17 (Th17) cells have a dual role in cancer, acting as both pro- and anti-tumorigenic factors. Understanding these complex interactions is key to developing effective cancer immunotherapies.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Interleukin (IL)-17 and IL-17-producing T helper 17 (Th17) cells are increasingly recognized for their complex roles in cancer.
- Existing literature suggests Th17 cells and IL-17 can promote or inhibit tumor development.
Purpose of the Study:
- To review the biological activities of Th17 cells and IL-17 in the context of cancer.
- To outline the interactions between Th17 cells and other immune cells within the tumor microenvironment.
- To discuss the dual role of Th17 cells and IL-17 in tumor progression and suppression.
Main Methods:
- Literature review of studies investigating IL-17 and Th17 cells in cancer.
- Analysis of immune cell interactions within the tumor microenvironment.
- Synthesis of evidence on the pro- and anti-tumorigenic functions of Th17 cells and IL-17.
Main Results:
- Th17 cells and IL-17 exhibit context-dependent pro- and anti-tumorigenic activities.
- Reciprocal interactions between Th17 cells and other immune cells modulate the tumor microenvironment.
- The specific role of Th17 cells and IL-17 is influenced by various regulatory processes.
Conclusions:
- A comprehensive understanding of Th17 cell and IL-17 regulation is crucial for advancing cancer immunotherapy.
- Targeting Th17 cell-mediated pathways holds potential for developing novel cancer treatments.
- Further research into the dual role of IL-17 in cancer is warranted for therapeutic development.
Related Concept Videos
The Tumor Microenvironment
The Tumor Microenvironment
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

